![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
A Medicine Company | Eli Lilly and Company
Lilly is a medicine company turning science into healing to make life better for people around the world.
About Us | Eli Lilly and Company
[Lilly logo and "A Medicine Company" appear over the last scene.] When health is lost, the only thing you want is to get better. In our relentless pursuit to help the most people around the world, our pipeline is focused on the following key areas:
Current Medicines - Eli Lilly and Company
Eli Lilly and Company works tirelessly to develop and deliver trusted medicines that meet real needs. These include Trulicity, Humalog, Alimta, Forteo, Taltz, Humulin, Basaglar, Jardiance, Cyramza, REYVOW, Verzenio, Emgality and more.
Find Your Career with Eli Lilly | Lilly Careers
Find your place at Lilly with Lilly Careers. For more than a century, we have united caring with discovery to make life better, join us today.
Contact Us - Eli Lilly and Company
We're here to answer questions related to Lilly medicines, devices or other inquiries.
About Eli Lilly and Company | Who We Are | Lilly
Lilly's Purpose: Lilly unites caring with discovery to create medicines that make life better for people around the world. Our Values: Three long-established core values guide Lilly in all that we do.
Home | Lilly Canada - Eli Lilly and Company
Lilly unites caring with discovery to create medicines that make life better for people around the world
Milestones of Lilly Caring and Discovery | Eli Lilly and Company
Lilly introduced Iletin ® (animal-source insulin, Lilly), the world's first commercially available insulin product, for the treatment of diabetes - then a fatal disease with no effective treatment options.
Home | Lilly Norge - Eli Lilly and Company
Lilly forener omsorg med innovasjon for å lage medisiner som gjør livet bedre for mennesker rundt om i verden.
Investors | Eli Lilly and Company
Jan 14, 2025 · The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.